Global and China Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021

 Table of Contents


Global and China Drugs for Treatment of Prostate Cancer Research Report to 2021
1 Drugs for Treatment of Prostate Cancer Overview and Each Type
1.1 Product Overview of Prostate Cancer
1.1.1 Definition and Product Scope of Drugs for Prostate Cancer
1.1.2 Global Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.13 China Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.2 Product Segments and Price of Each Type
1.2.1 Product Type of Key Manufacturers
1.2.2 Price List and of Each Type 2015 to 2016
1.2.3 Market Share and Growth Rate of Each Type
1.2.4 Triptorelin and Specification
1.2.5 Leuprorelin and Specification
1.2.6 Flutamide Tablets and Specification
1.2.7 Goserelin and Specification
1.2.8 Bicalutamide Tablets and Specification
1.2.9 Bicalutamide Capsules and Specification
1.2.10 Estramustine Phosphate Capsules and Specification
1.2.11 Mitoxantrone and Specification
1.2.12 Zytiga and Specification
1.2.13 Xtandi and Specification
1.3 Price List (Interviewed) of Each Type for Manufacturers 2015 and 2016
1.3.1 Price List (Interviewed) of Triptorelin by Manufacturers
1.3.2 Price List (Interviewed) of Leuprorelin by Key Manufacturers
1.3.3 Price List (Interviewed) of Flutamide Tablets by Manufacturers
1.3.4 Price List (Interviewed) of Goserelin by Manufacturers
1.3.5 Price List (Interviewed) of Bicalutamide Tablets by Manufacturers
1.3.6 Price List (Interviewed) of Bicalutamide Capsules by Manufacturers
1.3.7 Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers
1.3.8 Price List (Interviewed) of Mitoxantrone by Manufacturers
1.3.9 Price List (Interviewed) of Zytiga by Manufacturers
1.3.10 Price List (Interviewed) of Xtandi by Manufacturers
2 Competition Analysis by Manufacturers in Global and China
2.1 Global Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2015 to 2016
2.2 Global Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2015 to 2016
2.3 Global Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.4 China Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.5 China Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.6 China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
3 Sales and Revenue Segments of Each Type 2010 to 2015
3.1 Global Sales and Revenue Segments of Each Type 2010 to 2015
3.1.1 Global Sales and Market Share of Each Type 2010 to 2015
3.1.2 Global Sales Growth Rate of Each Type 2015 to 2016
3.1.3 Global Revenue and Market Share of Each Type 2015 to 2016
3.1.4 Global Revenue and Market Share of Each Type 2015 to 2016
3.2 Global Sales and Revenue Segments of Each Type 2015 to 2016
3.2.1 Global Sales and Market Share of Each Type 2015 to 2016
3.2.2 Global Sales Growth Rate of Each Type 2015 to 2016
3.2.3 Global Revenue and Market Share of Each Type 2015 to 2016
3.2.4 Global Revenue and Market Share of Each Type 2015 to 2016
4 Market Segments and Forecast of Drugs for Treatment of Prostate Cancer by Regions
4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021
4.1.1 Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021
4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021
4.2 Production and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021
4.2.1 Production and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021
4.2.2 Production Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021
4.3 US Market Forecast to 2021
4.3.1 US Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021
4.4 Western Europe Market Forecast to 2021
4.4.1 Western Europe Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021
4.5 Emerging Markets Market Forecast to 2021
4.5.1 Emerging Markets Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021
4.6 Established ROW Market Forecast to 2021
4.6.1 Established ROW Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021
4.7 Russia Market Forecast to 2021
4.7.1 Russia Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021
4.8 China Market Forecast to 2021
4.8.1 China Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021
5 Raw Materials and Applications
5.1 Key Raw Materials and Price Analysis for Triptorelin
5.1.1 Key Raw Materials for Triptorelin
5.1.2 Price Forecast of Key Raw Materials for Triptorelin 2016 to 2021
5.2 Key Raw Materials and Price Analysis for Leuprorelin
5.2.1 Key Raw Materials for Leuprorelin
5.2.2 Price Forecast of Key Raw Materials for Leuprorelin 2016 to 2021
5.3 Key Raw Materials and Price Analysis for Flutamide Tablets
5.3.1 Key Raw Materials for Flutamide Tablets
5.3.2 Price Forecast of Key Raw Materials for Flutamide Tablets 2016 to 2021
5.4 Key Raw Materials and Price Analysis for Goserelin
5.4.1 Key Raw Materials for Goserelin
5.4.2 Price Forecast of Key Raw Materials for Goserelin 2016 to 2021
5.5 Key Raw Materials and Price Analysis for Bicalutamide Tablets
5.5.1 Key Raw Materials for Bicalutamide Tablets
5.5.2 Price Forecast of Key Raw Materials for Bicalutamide Tablets 2016 to 2021
5.6 Key Raw Materials and Price Analysis for Bicalutamide Capsules
5.6.1 Key Raw Materials for Bicalutamide Capsules
5.6.2 Price Forecast of Key Raw Materials for Bicalutamide Capsules 2016 to 2021
5.7 Key Raw Materials and Price Analysis for Estramustine Phosphate Capsules
5.7.1 Key Raw Materials for Estramustine Phosphate Capsules
5.7.2 Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 2016 to 2021
5.8 Key Raw Materials and Price Analysis for Mitoxantrone
5.8.1 Key Raw Materials for Mitoxantrone
5.8.2 Price Forecast of Key Raw Materials for Mitoxantrone 2016 to 2021
5.9 Key Raw Materials and Price Analysis for Zytiga
5.9.1 Key Raw Materials for Zytiga
5.9.2 Price Forecast of Key Raw Materials for Zytiga 2016 to 2021
5.10 Key Raw Materials and Price Analysis for Xtandi
5.10.1 Key Raw Materials for Xtandi
5.10.2 Price Forecast of Key Raw Materials for Xtandi 2016 to 2021
5.11 Applications of Triptorelin
5.12 Applications of Leuprorelin
5.13 Applications of Flutamide Tablets
5.14 Applications of Goserelin
5.15 Applications of Bicalutamide Tablets
5.16 Applications of Bicalutamide Capsules
5.17 Applications of Estramustine Phosphate Capsules
5.18 Applications of Mitoxantrone
5.19 Applications of Zytiga
5.20 Applications of Xtandi
6 Key Manufacturers Analysis of Drugs for Treatment of Prostate Cancer
6.1 IPSEN
6.1.1 IPSEN Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.1.4 Interviewee, Name and Contact
6.2 Ferring Pharmaceuticals
6.2.1 Company Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.2.4 Interviewee, Name and Contact
6.3 Chengdu Tiantaishan pharmaceutical
6.3.1 Company Basic Information
6.3.2 Triptorelin (Specification and Price)
6.3.3 Sales Value, Gross Margin 2011-2016
6.3.4 Interviewee, Name and Contact
6.4 GeneScience Pharmaceuticals
6.4.1 Company Basic Information
6.4.2 Triptorelin (Specification and Price)
6.4.3 Sales Value, Gross Margin 2011-2016
6.4.4 Interviewee, Name and Contact
6.5 Takeda Pharmaceutical Company Limited
6.5.1 Company Basic Information
6.5.2 Leuprorelin (Specification and Price)
6.5.3 Sales Value, Gross Margin 2011-2016
6.5.4 Interviewee, Name and Contact
6.6 Beijing Biote Pharmaceutical
6.6.1 Company Basic Information
6.6.2 Leuprorelin (Specification and Price)
6.6.3 Sales Value, Gross Margin 2011-2016
6.6.4 Interviewee, Name and Contact
6.7 Livzon Pharmaceutical Group
6.7.1 Company Basic Information
6.7.2 Leuprorelin (Specification and Price)
6.7.3 Sales Value, Gross Margin 2011-2016
6.7.4 Interviewee, Name and Contact
6.8 Schering-Plough Canada
6.8.1 Company Basic Information
6.8.2 Flutamide Tablets (Specification and Price)
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.4 Interviewee, Name and Contact
6.9  JiangSu TASLY DI YI Pharmaceutical
6.9.1 Company Basic Information
6.9.2 Flutamide Tablets (Specification and Price)
6.9.3 Sales Value, Gross Margin 2011-2016
6.9.4 Interviewee, Name and Contact
6.10 Shanghai Fudan Fuhua Pharmaceutical
6.10.1 Company Basic Information
6.10.2 Flutamide Tablets (Specification and Price)
6.10.3 Sales Value, Gross Margin 2011-2016
6.10.4 Interviewee, Name and Contact
6.11 S.C.SINDAN-PHARMA S.R.L.
6.11.1 Company Basic Information
6.11.2 Flutamide Tablets (Specification and Price)
6.11.3 Sales Value, Gross Margin 2011-2016
6.11.4 Interviewee, Name and Contact
6.12 AstraZeneca
6.12.1 Company Basic Information
6.12.2 Goserelin (Specification and Price)
6.12.3 Sales Value, Gross Margin 2011-2016
6.12.4 Interviewee, Name and Contact
6.13 Corden Pharma GmbH
6.13.1 Company Basic Information
6.13.2 Bicalutamide Tablets (Specification and Price)
6.13.3 Sales Value, Gross Margin 2011-2016
6.13.4 Interviewee, Name and Contact
6.14 Shanghai Zhaohui Pharmaceutical
6.14.1 Company Basic Information
6.14.2 Bicalutamide Tablets (Specification and Price)
6.14.3 Sales Value, Gross Margin 2011-2016
6.14.4 Interviewee, Name and Contact
6.15 HISUN Pharmaceutical
6.15.1 Company Basic Information
6.15.2 Bicalutamide Tablets (Specification and Price)
6.15.3 Sales Value, Gross Margin 2011-2016
6.15.4 Interviewee, Name and Contact
6.16 Shanxi Zhendong Pharmaceutical
6.16.1 Company Basic Information
6.16.2 Bicalutamide Capsules (Specification and Price)
6.16.3 Sales Value, Gross Margin 2011-2016
6.16.4 Interviewee, Name and Contact
6.17 Pfizer
6.17.1 Company Basic Information
6.17.2 Estramustine Phosphate Capsules (Specification and Price)
6.17.3 Sales Value, Gross Margin 2011-2016
6.17.4 Interviewee, Name and Contact
6.18 Sichuan sunnyhope pharmaceutical
6.18.1 Company Basic Information
6.18.2 Mitoxantrone (Specification and Price)
6.18.3 Sales Value, Gross Margin 2011-2016
6.18.4 Interviewee, Name and Contact
6.19 Luoxin Group
6.19.1 Company Basic Information
6.19.2 Mitoxantrone (Specification and Price)
6.19.3 Sales Value, Gross Margin 2011-2016
6.19.4 Interviewee, Name and Contact
6.20 Jiangsu Aosaikang Pharmaceutical
6.20.1 Company Basic Information
6.20.2 Mitoxantrone (Specification and Price)
6.20.3 Sales Value, Gross Margin 2011-2016
6.20.4 Interviewee, Name and Contact
6.21 JIANG SU HENG RUI MEDICINE
6.21.1 Company Basic Information
6.21.2 Mitoxantrone (Specification and Price)
6.21.3 Sales Value, Gross Margin 2011-2016
6.21.4 Interviewee, Name and Contact
6.22 Johnson
6.22.1 Company Basic Information
6.22.2 Zytiga (Specification and Price)
6.22.3 Sales Value, Gross Margin 2011-2016
6.22.4 Interviewee, Name and Contact
6.23 Astellas
6.23.1 Company Basic Information
6.23.2 Xtandi (Specification and Price)
6.23.3 Sales Value, Gross Margin 2011-2016
6.23.4 Interviewee, Name and Contact
7 Technology Development Trend
7.1 Manufacturing Process of Drugs for Treatment of Prostate Cancer
7.2 Analysis of Manufacturing Process
7.3 Development Trend
8 Research Findings and Conclusion

List of Tables and Figures


Figure Picture of Drugs for Prostate Cancer	14
Figure Global Market Size (Value) of Drugs for Prostate Cancer 2016-2021	14
Figure Global Market Size (Volume) of Drugs for Prostate Cancer 2016-2021	14
Figure China Market Size (Value) of Drugs for Prostate Cancer 2016-2021	14
Figure China Market Size (Volume) of Drugs for Prostate Cancer 2016-2021	15
Table Product Type of Key Manufacturers	15
Table Price List and Forecast of Each Type	15
Table Market Share of Each Type	15
Figure Growth Rate of Each Type 2015 to 2016	16
Figure Picture of Triptorelin	16
Table Specification of Triptorelin	16
Figure Picture of Leuprorelin	16
Table Specification of Leuprorelin	17
Figure Picture of Flutamide Tablets	17
Table Specification of Flutamide Tablets	17
Figure Picture of Goserelin	17
Table Specification of Goserelin	17
Figure Picture of Bicalutamide Tablets	17
Table Specification of Bicalutamide Tablets	17
Figure Picture of Type Bicalutamide Capsules	17
Table Specification of Type Bicalutamide Capsules	18
Figure Picture of Estramustine Phosphate Capsules	18
Table Specification of Estramustine Phosphate Capsules	18
Figure Picture of Mitoxantrone	18
Table Specification of Mitoxantrone	18
Figure Picture of Zytiga	18
Table Specification of Zytiga	18
Figure Picture of Xtandi	19
Table Specification of Xtandi	19
Table Price List (Interviewed) of Triptorelin by Manufacturers 2015 and 2016	19
Table Price List (Interviewed) of Leuprorelin by Manufacturers 2015 and 2016	20
Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016	20
Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016	21
Table Price List (Interviewed) of Bicalutamide Tablets by Manufacturers 2015 and 2016	21
Table Price List (Interviewed) of Bicalutamide Capsules by Manufacturers 2015 and 2016	22
Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016	22
Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016	23
Table Price List (Interviewed) of Zytiga Phosphate Capsules by Manufacturers 2015 and 2016	23
Table Price List (Interviewed) of Xtandi Phosphate Capsules by Manufacturers 2015 and 2016	24
Table Global Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2015 to 2016	25
Table Global Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2015 to 2016	25
Table Global Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2015 to 2016	26
Table Global Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2015 to 2016	26
Table Global Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016	27
Table China Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015	28
Table China Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015	28
Table China Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015	29
Table China Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015	29
Table China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016	30
Table Global Sales of Each Type 2010 to 2015	31
Table Global Sales Market Share of Each Type 2010 to 2015	31
Table Global Sales Growth Rate of Each Type 2015 to 2016	31
Table Global Revenue of Each Type 2015 to 2016	32
Table Global Revenue Market Share of Each Type 2015 to 2016	32
Table Global Revenue of Each Type 2015 to 2016	32
Table Global Revenue Market Share of Each Type 2015 to 2016	33
Table China Sales of Each Type 2015 to 2016	33
Table China Sales Market Share of Each Type 2015 to 2016	33
Table Global Sales Growth Rate of Each Type 2015 to 2016	33
Table China Revenue of Each Type 2015 to 2016	34
Table China Revenue Market Share of Each Type 2015 to 2016	34
Table China Revenue of Each Type 2015 to 2016	34
Table China Revenue Market Share of Each Type 2015 to 2016	35
Table Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021	36
Figure Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021	37
Table North America Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2015 to 2020	37
Table Europe Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2015 to 2020	38
Table Japan Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021	38
Table India Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021	39
Table Southeast Asia Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021	39
Table China Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021	40
Table Key Raw Materials for Triptorelin	41
Table Price Forecast of Key Raw Materials for Triptorelin	41
Table Key Raw Materials for Leuprorelin	42
Table Price Forecast of Key Raw Materials for Leuprorelin	42
Table Key Raw Materials for Flutamide Tablets	42
Table Price Forecast of Key Raw Materials for Flutamide Tablets	43
Table Key Raw Materials for Goserelin	43
Table Price Forecast of Key Raw Materials for Goserelin	43
Table Key Raw Materials for Bicalutamide Tablets	44
Table Price Forecast of Key Raw Materials for Bicalutamide Tablets	44
Table Key Raw Materials for Bicalutamide Capsules	45
Table Price Forecast of Key Raw Materials for Bicalutamide Capsules	45
Table Key Raw Materials for Estramustine Phosphate Capsules	45
Table Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules	46
Table Key Raw Materials for Mitoxantrone	46
Table Price Forecast of Key Raw Materials for Mitoxantrone	47
Table Key Raw Materials for Zytiga	47
Table Price Forecast of Key Raw Materials for Zytiga	47
Table Key Raw Materials for Xtandi	48
Table Price Forecast of Key Raw Materials for Zytiga	48
Table Applications of Triptorelin	48
Table Applications of Leuprorelin	49
Table Applications of Flutamide Tablets	49
Table Applications of Goserelin	49
Table Applications of Bicalutamide Tablets	49
Table Applications of Bicalutamide Capsules	50
Table Applications of Estramustine Phosphate Capsules	50
Table Applications of Mitoxantrone	50
Table Applications of Zytiga	51
Table Applications of Xtandi	51
Table IPSEN Basic Information List	52
Table Specification, Price, Sales Value and Market Share of IPSEN	52
Table Sales Value, Gross Margin and Growth rate of IPSEN	52
Figure Product Sales Value, Growth rate of IPSEN	53
Table Ferring Pharmaceuticals Basic Information List	53
Table Specification, Price, Sales Value and Market Share of Ferring Pharmaceuticals	53
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals	54
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals	54
Table Chengdu Tiantaishan pharmaceutical Basic Information List	54
Table Specification, Price, Sales Value and Market Share of Chengdu Tiantaishan pharmaceutical	55
Table Sales Value, Gross Margin and Growth rate of Chengdu Tiantaishan pharmaceutical	55
Figure Product Sales Value, Growth rate of Chengdu Tiantaishan pharmaceutical	55
Table GeneScience Pharmaceuticals Basic Information List	55
Table Specification, Price, Sales Value and Market Share of GeneScience Pharmaceuticals	56
Table Sales Value, Gross Margin and Growth rate of GeneScience Pharmaceuticals	56
Figure Product Sales Value, Growth rate of GeneScience Pharmaceuticals	56
Table Takeda Pharmaceutical Company Limited Basic Information List	57
Table Specification, Price, Sales Value and Market Share of Takeda Pharmaceutical Company Limited	57
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited	57
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited	58
Table Beijing Biote Pharmaceutical Basic Information List	58
Table Specification, Price, Sales Value and Market Share of Beijing Biote Pharmaceutical	58
Table Sales Value, Gross Margin and Growth rate of Beijing Biote Pharmaceutical	59
Figure Product Sales Value, Growth rate of Beijing Biote Pharmaceutical	59
Table Livzon Pharmaceutical Group Basic Information List	59
Table Specification, Price, Sales Value and Market Share of Livzon Pharmaceutical Group	60
Table Sales Value, Gross Margin and Growth rate of Livzon Pharmaceutical Group	60
Figure Product Sales Value, Growth rate of Livzon Pharmaceutical Group	60
Table Schering-Plough Canada Basic Information List	60
Table Specification, Price, Sales Value and Market Share of Schering-Plough Canada	61
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada	61
Figure Product Sales Value, Growth rate of Schering-Plough Canada	61
Table JiangSu TASLY DI YI Pharmaceutical Basic Information List	61
Table Specification, Price, Sales Value and Market Share of JiangSu TASLY DI YI Pharmaceutical	62
Table Sales Value, Gross Margin and Growth rate of JiangSu TASLY DI YI Pharmaceutical	62
Figure Product Sales Value, Growth rate of JiangSu TASLY DI YI Pharmaceutical	62
Table Shanghai Fudan Fuhua Pharmaceutical Basic Information List	63
Table Specification, Price, Sales Value and Market Share of Shanghai Fudan Fuhua Pharmaceutical	63
Table Sales Value, Gross Margin and Growth rate of Shanghai Fudan Fuhua Pharmaceutical	63
Figure Product Sales Value, Growth rate of Shanghai Fudan Fuhua Pharmaceutical	64
Table S.C.SINDAN-PHARMA S.R.L. Basic Information List	64
Table Specification, Price, Sales Value and Market Share of S.C.SINDAN-PHARMA S.R.L.	64
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L.	64
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L.	65
Table AstraZeneca Basic Information List	65
Table Specification, Price, Sales Value and Market Share of Pfizer	65
Table Sales Value, Gross Margin and Growth rate of AstraZeneca	66
Figure Product Sales Value, Growth rate of AstraZeneca	66
Table Corden Pharma GmbH Basic Information List	66
Table Specification, Price, Sales Value and Market Share of Corden Pharma GmbH	67
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH	67
Figure Product Sales Value, Growth rate of Corden Pharma GmbH	67
Table Shanghai Zhaohui Pharmaceutical Basic Information List	67
Table Specification, Price, Sales Value and Market Share of Shanghai Zhaohui Pharmaceutical	68
Table Sales Value, Gross Margin and Growth rate of Shanghai Zhaohui Pharmaceutical	68
Figure Product Sales Value, Growth rate of Shanghai Zhaohui Pharmaceutical	68
Table HISUN Pharmaceutical Basic Information List	69
Table Specification, Price, Sales Value and Market Share of HISUN Pharmaceutical	69
Table Sales Value, Gross Margin and Growth rate of HISUN Pharmaceutical	69
Figure Product Sales Value (M USD), Growth rate of HISUN Pharmaceutical	70
Table Shanxi Zhendong Pharmaceutical Basic Information List	70
Table Specification, Price, Sales Value and Market Share of Shanxi Zhendong Pharmaceutical	70
Table Sales Value, Gross Margin and Growth rate of Shanxi Zhendong Pharmaceutical	70
Figure Product Sales Value, Growth rate of Shanxi Zhendong Pharmaceutical	71
Table Pfizer Basic Information List	71
Table Specification, Price, Sales Value and Market Share of Pfizer	71
Table Sales Value, Gross Margin and Growth rate of Pfizer	72
Figure Product Sales Value, Growth rate of Pfizer	72
Table Sichuan sunnyhope pharmaceutical Basic Information List	72
Table Specification, Price, Sales Value and Market Share of Sichuan sunnyhope pharmaceutical	73
Table Sales Value, Gross Margin and Growth rate of Sichuan sunnyhope pharmaceutical	73
Figure Product Sales Value, Growth rate of Sichuan sunnyhope pharmaceutical	73
Table Luoxin Group Basic Information List	73
Table Specification, Price, Sales Value and Market Share of Luoxin Group	74
Table Sales Value, Gross Margin and Growth rate of Luoxin Group	74
Figure Product Sales Value, Growth rate of Luoxin Group	74
Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List	75
Table Specification, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical	75
Table Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical	75
Figure Product Sales Value, Growth rate of Jiangsu Aosaikang Pharmaceutical	76
Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List	76
Table Specification, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE	76
Table Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE	77
Figure Product Sales Value, Growth rate of JIANG SU HENG RUI MEDICINE	77
Table Johnson Basic Information List	77
Table Specification, Price, Sales Value and Market Share of Johnson	78
Table Sales Value, Gross Margin and Growth rate of Johnson	78
Figure Product Sales Value, Growth rate of Johnson	78
Table Astellas Basic Information List	78
Table Specification, Price, Sales Value and Market Share of Astellas	79
Table Sales Value, Gross Margin and Growth rate of Astellas	79
Figure Product Sales Value, Growth rate of Astellas	79

 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy